beta-escin has been researched along with Brain-Edema* in 13 studies
1 trial(s) available for beta-escin and Brain-Edema
Article | Year |
---|---|
[Advances in the conservative treatment of acute traumatic cerebral edema. Controlled clinical trial with follow-up examination (author's transl)].
Studies in 142 accident victims with severe craniocerebral trauma showed that the intravenous application of sodium escinate over several days considerably reduced the dangerous rise in intracranial pressure and also the total mortality in comparison with corticosteroid therapy alone. Both groups, each of 71 patients, were adjusted from an initial intraventricular pressure of 500--250 mm H2O to the same basic pressure of 150 mm H2O hydrostatically. In the same way, sodium escinate shortened the duration of unconsciousness. The renal function in patients was good. Follow-up examinations at least 2 to a maximum of 3.5 years after the accident and treatment showed a significantly higher rehabilitation rate in the sodium escinate group. Topics: Adrenal Cortex Hormones; Blood Transfusion; Brain Edema; Brain Injuries; Escin; Female; Humans; Injections, Intravenous; Intracranial Pressure; Male; Saponins; Vitamin B Complex | 1979 |
12 other study(ies) available for beta-escin and Brain-Edema
Article | Year |
---|---|
[Efficacy of the anti-edema drug L-lysine aescinat in stroke].
Forty-nine patients with ischemic hemispheric stroke admitted within 48 hours of stroke onset were studied. Twenty-nine patients (the main group) received L-lysine aescinat as an anti-edema drug. The efficacy was evaluated clinically and by EEG and autonomic testing. The rapid recovery of wakefulness and reduction in neurological deficit as well as the improvement of brain electrical activity and autonomic functions were observed. L-lysine aescinat can be recommended to control the syndrome of intracranial hypertension in stroke. Topics: Adult; Aged; Brain Edema; Escin; Female; Glasgow Outcome Scale; Humans; Intracranial Hypertension; Lysine; Male; Middle Aged; Stroke; Treatment Outcome | 2012 |
Escin attenuates cerebral edema induced by acute omethoate poisoning.
Organophosphorus exposure affects different organs such as skeletal muscles, the gastrointestinal tract, liver, lung, and brain. The present experiment aimed to evaluate the effect of escin on cerebral edema induced by acute omethoate poisoning. Sprague-Dawley rats were administered subcutaneously with omethoate at a single dose of 60 mg/kg followed by escin treatment. The results showed that escin reduced the brain water content and the amount of Evans blue in omethoate-poisoned animals. Treatment with escin decreased the levels of tumor necrosis factor-alpha (TNF-α), matrix metalloproteinase-9 (MMP-9), cyclooxygenase-2 (COX-2), and prostaglandin E₂ (PGE₂) in the brain. Escin also alleviated the histopathological change induced by acute omethoate poisoning. The findings demonstrated that escin can attenuate cerebral edema induced by acute omethoate poisoning, and the underlying mechanism was associated with ameliorating the permeability of the blood-brain barrier. Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Brain Edema; Cardiovascular Agents; Cyclooxygenase 2; Dimethoate; Dinoprostone; Escin; Insecticides; Matrix Metalloproteinase 9; Permeability; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2011 |
Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats.
To investigate the inhibiting effect of beta-Aescin on nuclear factor-kappaB (NF-kappaB) activation and the expression of tumor necrosis factor-alpha (TNF-alpha) protein after traumatic brain injury (TBI) in the rat brain, 62 SD rats were subjected to lateral cortical impact injury caused by a free-falling object and divided randomly into four groups: (1) sham operated (Group A); (2) injured (Group B); (3) beta-Aescin treatment (Group C); (4) pyrrolidine dithocarbamate (PDTC) treatment (Group D). Beta-Aescin was administered in Group C and PDTC treated in Group D immediately after injury. A series of brain samples were obtained directly 6 h, 24 h and 3 d respectively after trauma in four groups. NF-kappaB activation was examined by Electrophoretic Mobility Shift Assay (EMSA); the levels of TNF-alpha protein were measured by radio-immunoassay (RIA); the water content of rat brain was measured and pathomorphological observation was carried out. NF-kappaB activation, the levels of TNF-alpha protein and the water content of rat brain were significantly increased (P<0.01) following TBI in rats. Compared with Group B, NF-kappaB activation (P<0.01), the levels of TNF-alpha protein (P<0.01) and the water content of brain (P<0.05) began to decrease obviously after injury in Groups C and D. Beta-Aescin could dramatically inhibit NF-kappaB activation and the expression of TNF-alpha protein in the rat brain, alleviate rat brain edema, and that could partially be the molecular mechanism by which beta-Aescin attenuates traumatic brain edema. Topics: Animals; Body Water; Brain Edema; Brain Injuries; Escin; NF-kappa B; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
[Therapy of brain edema in craniocerebral trauma].
Topics: Brain Edema; Brain Injuries; Dexamethasone; Escin; Humans; Hypertonic Solutions; Intracranial Pressure | 1985 |
[Treatment and follow-up treatment in head injuries (author's transl)].
The treatment and follow-up treatment of head injuries patients requires a drug, which will combat the development of cerebral edema by acting on the blood-brain barrier and restoring the normal function of endothelium and basal membrane. Such a drug should be easy to administer and free from serious side-effects, so that it can be employed for follow-up treatment by the general practitioner without the necessity of hospital facilities (EEG, CT, etc.). In a series of 3557 patients with head injuries Reparil has shown to be a suitable drug in treatment and follow-up treatment of posttraumatic brain edema. In follow-up treatment close medical supervision is essential so that any complications such as intracranial haematomas can be recognized in good time. This applies in particular to patients in high risk groups (advanced age, presence of concurrent diseases, in particular metabolic and circulatory disturbances). Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain Edema; Brain Injuries; Child; Child, Preschool; Escin; Female; Humans; Infant; Intracranial Pressure; Male; Middle Aged; Tomography, X-Ray Computed | 1981 |
[Anti-edema effect of escin at the cerebral level].
Topics: Brain Edema; Brain Neoplasms; Drug Evaluation; Escin; Humans; Injections, Intravenous; Intracranial Pressure; Preoperative Care; Saponins | 1978 |
[Patients with head injuries brought in by helicopter].
Topics: Adolescent; Adult; Aircraft; Angiography; Brain Edema; Carotid Arteries; Child; Child, Preschool; Craniocerebral Trauma; Dexamethasone; Encephalitis; Escin; Female; First Aid; Hematoma, Epidural, Cranial; Humans; Hydrocephalus; Infant; Male; Middle Aged; Pneumonia; Transportation of Patients | 1977 |
[Treatment of skull and brain damaged patients by the general practitioner].
Topics: Brain Edema; Brain Injuries; Dexamethasone; Escin; First Aid; Home Nursing; Hospitalization; Humans; Physicians, Family; Skull | 1976 |
[Possible therapeutic influences on experimentally induced edemas (author's transl)].
In pathogenetically different models the antiedemic effect of extractum hippocastani semen (EHS) for intravenous and oral use was to be demonstrated. The histamine-induced edema of the skin, the postischemic edema of muscle and the cerebral edema provoked by cold injury were used. In all the models tested, it was possible to obtain reproducible numerical results which made statistical evaluation of the experiments possible. Antiedemic protective effects could be demonstrated in all investigations, whereas in one model a curative effect could be proved, too. Topics: Brain Edema; Cold Temperature; Disease Models, Animal; Edema; Escin; Histamine; Ischemia; Muscles; Muscular Diseases; Plant Extracts; Plants, Medicinal; Skin Diseases | 1976 |
[The treatment of traumatic brain edema].
Topics: Aprotinin; Brain Edema; Brain Injuries; Dihydroergotamine; Diuretics; Escin; Glucocorticoids; Humans; Parasympatholytics; Trephining | 1976 |
[Treatment of traumatic brain edema].
Topics: Adolescent; Adult; Aged; Brain Edema; Brain Injuries; Child; Child, Preschool; Dexamethasone; Diuretics; Escin; Female; Humans; Infant; Male; Mannitol; Middle Aged; Parasympatholytics; Sorbitol | 1975 |
[A contribution to the pathophysiology of post-traumatic brain oedema (author's transl)].
The aim of this paper is to contrast new results obtained on the activities of lysosomal proteases in the brain of traumatized animals with the previously held opinions concerning the development of post-traumatic brain oedema. Two hours after a standardized head injury in the cat, acid and neutral proteases were determined in the brain homogenate. Total as well as free activity, especially of the neutral proteases, were markedly increased after head injury, a circumstance indicating the important role of lysosomes in the development of post-traumatic brain oedema. It is postulated that not hypoxia alone, but primary or secondary disturbance of lysosomal function is the predominant factor in the development of brain oedema. Release of enzymes -- especially proteases -- causes irreversibility of initial vascular oedema by autolysis of cellular structures. Topics: Animals; Brain Edema; Brain Injuries; Cats; Cortisone; Diuretics; Escin; Lysosomes; Peptide Hydrolases | 1975 |